Abstract:An overview of the representative compounds of withanolides as well as their anticancer mechanisms, regulated signaling pathways, and their potential for clinical translation. Natural products have played a significant role throughout history in the prevention and treatment of numerous diseases, particularly cancers. As a natural product primarily derived from various medicinal plants in the Withania genus, withanolides have been shown in several studies to exhibit potential activities in cancer treatment. Consequently, understanding the molecular mechanism of withanolides could herald the discovery of new anticancer agents. Withanolides have been studied widely, especially in the last 20 years, and attracted the attention of numerous researchers. Currently, over 1200 withanolides have been classified, with approximately a quarter of them having been reported in the literature to be able to modulate the survival and death of cancer cells through multiple avenues. To what extent, though, has the anticancer effects of these compounds been studied? How far are they from being developed into clinical drugs? What are their potential, characteristic features, and challenges? In this review, we elaborate on the current knowledge of natural compounds belonging to this class and provide an overview of their natural sources, anticancer activity, mechanism of action, molecular targets, and implications for anticancer drug research. In addition, direct targets and clinical research to guide the design and implementation of future preclinical and clinical studies to accelerate the application of withanolides have been highlighted.

Withanolides from the genus Physalis: a review on their phytochemical and pharmacological aspects

New Anti-Inflammatory Withanolides from Physalis Pubescens Fruit

Anti-inflammatory and Cytotoxic Withanolides from Physalis Minima

Withanolides from <i>Physalis angulata</i> var. <i>villosa</i> and the Relative Configurational Revision of Some Known Analogs

Anti-inflammatory Withanolides from Physalis Minima

UPLC-Q-Orbitrap-MS/MS-Guided Isolation of Bioactive Withanolides from the Fruits of Physalis angulata

Induction of Quinone Reductase (QR) by Withanolides Isolated from Physalis Pubescens L. (Solanaceae).

New Cytotoxic Withanolides from Physalis Peruviana

Anti-inflammatory Withanolides from the Aerial Parts of Physalis Minima.

Naturally occurring physalins from the genus Physalis: A review

Natural withanolides, an update

Withaperuvin O, a new withanolide from Physalis peruviana L

Cytotoxic Physalins from Aeroponically Grown Physalis acutifolia

Induction of Quinone Reductase (QR) by Withanolides Isolated from Physalis Angulata L. Var. Villosa Bonati (Solanaceae).

Withaphysanolide A, a novel C-27 norwithanolide skeleton, and other cytotoxic compounds from Physalis divericata

Withaminimas A-F, Six Withanolides with Potential Anti-Inflammatory Activity from Physalis Minima.

Discovery of physalin biosynthesis and structure modification of physalins in Physalis alkekengi L. var. Franchetii

Withanolides: Promising candidates for cancer therapy

Physalins V-IX, 16,24-cyclo-13,14-seco withanolides from Physalis angulata and their antiproliferative and anti-inflammatory activities

Withaphysalin-Type Withanolides from Physalis Minima

Physalins and Withanolides from the Fruits of Physalis Alkekengi L. Var. Franchetii (mast.) Makino and the Inhibitory Activities Against Human Tumor Cells